Searched for
PHARMA STAKEHOLDERS
Capacity augmentation, value-added applications critical for making India leader in stainless steel productionWith a growing domestic market and potential in sectors like green hydrogen and pharmaceuticals, India aims to be a manufacturing and innov...- Hyderabad Economic Forum 2026 brings together 500+ leaders at SAS ITOWER to chart the city’s next growth chapterHyderabad's economic future took center stage at the inaugural Hyderabad Economic Forum 2026, themed 'One City. One Vision. Infinite Possib...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
- Drug regulator drafts guidelines on high-risk solvents after tainted syrup deaths in kidsIndia's drug regulator is creating new rules for dangerous solvents in children's medicines. This follows tragic deaths linked to contamina...
- Drugmakers must report safety data from launch date, not approval date: CDSCOIndia's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...
- Two separate venues for pharma industry expos in Delhi-NCRCPHI India and PMEC India are expanding their pharmaceutical expos to two venues in Delhi-NCR. This move aims to support the rapid growth o...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- ET Family Business Awards: Torrent Pharma drives growth through acquisitions and innovationAman Mehta is guiding Torrent Pharmaceuticals through a significant period of growth and strategic change. He is driving the company's expa...
- Around 10.10 lakh passengers travelled to India since February 28 from region amid West Asia tensions, says GovtIndia is ensuring smooth functioning across key sectors amidst the West Asia situation. The Petroleum Ministry guarantees uninterrupted fue...
- India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...
- Lalitpur Pharma Park gets export push as UPSIDA, JNPA sign pactUttar Pradesh State Industrial Development Authority and Jawaharlal Nehru Port Authority have partnered. This agreement aims to make the La...
- Piyush Goyal meets pharma stakeholders to discuss growth, regulation amid global tariff concernsUnion Minister Piyush Goyal met with Indian pharmaceutical stakeholders. Discussions focused on strengthening regulatory frameworks and acc...
- Panel to suggest ways to strengthen supply chains, cut dependence on China for pharma productsThe Department of Pharmaceuticals (DoP) has formed a technical committee to create a strategy and roadmap to strengthen supply chains and r...
- Proxy advisors vote against Strides Pharma’s consolidation schemeProxy advisory firms have recommended investors vote against Strides Pharma's proposal to consolidate businesses with Steriscience and Ones...
- Pharma industry’s costly transition to sustainability can be made lucrativeRise in production costs have discouraged the pharma sector move towards decarbonisation. But the long-term advantages of going green shoul...
- 'Indian bio-pharma R&D spending could grow to $25 bn by 2025'India's bio-pharma sector may see a surge in R&D spending to about $25 billion in the next 15 years, according to a Boston Consulting Group...
Load More
